This content is from: Germany

Latest developments in SPC's: Patent term extensions

Changes in supplementary protection certificates can mean a difference of millions of euros per month for the value of pharmaceutical products, say Dr Martin Huenges and Dr Dirk Bühler of Maiwald

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial